Scarica l'app Stockscreener
1.74
3.11%
-0.03
Precedente Chiudi:
$1.77
Aprire:
$1.75
Volume 24 ore:
50,255
Relative Volume:
0.39
Capitalizzazione di mercato:
$4.00M
Reddito:
$294.20K
Utile/perdita netta:
$-12.25M
Rapporto P/E:
-0.3446
EPS:
-5.05
Flusso di cassa netto:
$-10.77M
1 W Prestazione:
-15.10%
1M Prestazione:
+325.88%
6M Prestazione:
+159.61%
1 anno Prestazione:
+154.07%
Intervallo 1D:
$1.71
$1.77
Intervallo di 1 settimana:
$1.67
$2.09
Portata 52W:
$0.2375
$2.875
Aethlon Medical Inc Stock (AEMD) Company Profile
Nome
Aethlon Medical Inc
Settore
Industria
Telefono
619-941-0360
Indirizzo
11555 SORRENTO VALLEY ROAD, SUITE 203, SAN DIEGO, CA
Confronta AEMD con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
AEMD
Aethlon Medical Inc
|
1.72 | 4.00M | 294.20K | -12.25M | -10.77M | -5.05 |
|
ABT
Abbott Laboratories
|
132.18 | 233.36B | 42.34B | 13.50B | 6.66B | 7.71 |
|
SYK
Stryker Corp
|
373.41 | 147.15B | 23.22B | 2.86B | 3.58B | 7.40 |
|
BSX
Boston Scientific Corp
|
101.51 | 146.97B | 17.55B | 2.03B | 2.72B | 1.37 |
|
MDT
Medtronic Plc
|
85.89 | 112.76B | 33.54B | 4.66B | 5.19B | 3.62 |
|
EW
Edwards Lifesciences Corp
|
73.14 | 44.46B | 5.54B | 4.18B | 623.10M | 7.00 |
Aethlon Medical Inc Borsa (AEMD) Ultime notizie
AEMD Reaches Milestone in Australian Hemopurifier Trial | AEMD Stock News - GuruFocus
Aethlon Medical Treats Second Patient in Australian Hemopurifier® Cancer Trial | AEMD Stock News - GuruFocus
Cancer Trial Breakthrough: Aethlon's Hemopurifier Shows Promise in Treating Therapy-Resistant Tumors - Stock Titan
Aethlon Medical at Emerging Growth Conference 83: Strategic Updates on Hemopurifier By Investing.com - Investing.com South Africa
Aethlon Medical at Emerging Growth Conference 83: Strategic Updates on Hemopurifier - Investing.com Australia
Presenting on Emerging Growth Conference 83 Day 2 on June 18; Register to live stream - GlobeNewswire Inc.
AEMD: Virtual Meeting With Management, Upcoming Presentation of Data in Long Covid - Yahoo Finance
Aethlon Medical, Inc. (NASDAQ:AEMD) Sees Significant Drop in Short Interest - Defense World
Medical Tech NewsAethlon Medical (NASDAQ: AEMD) to Present New Pre-Clinical Data on Long COVID and Post-Acute Infection Syndromes - Investorideas.com
AEMD to Present on Long COVID at Keystone Symposium | AEMD Stock News - GuruFocus
Aethlon Medical to Present New Pre-Clinical Data at the Keystone Symposium on Long COVID and Other Post-Acute Infection Syndromes | AEMD Stock News - GuruFocus
Aethlon Medical to Present New Pre-Clinical Data at the Keystone Symposium on Long COVID and Other Post-Acute Infection Syndromes - Yahoo Finance
Potential Long COVID Treatment Breakthrough: Aethlon Medical's Device Shows Promise for 48M Patients - Stock Titan
AEMD Trading Halted Pending Important Announcement | AEMD Stock News - GuruFocus
Exosome Therapy Market May See a Big Move | Major Giants- Exiqon, Exosome Diagnostic, NanoSomix - openPR.com
aethlon medical announces reverse stock split effective june 6 By Investing.com - Investing.com South Africa
Aethlon Medical Approves Reverse Stock Split Plan - TipRanks
aethlon medical announces reverse stock split effective june 6 - Investing.com
Aethlon Medical, Inc. (NASDAQ:AEMD) Short Interest Update - Defense World
Exosomes Market Projected to Reach USD 1,311.03 Million by - GlobeNewswire
Aethlon Adds to Board - Medical Product Outsourcing
FDA Grants Aethlon Compassionate Use Approval for its Hemopurifier to Help Fight Ebola - Medical Product Outsourcing
FDA OKs Aethlon to Export Hemopurifier to India - Medical Product Outsourcing
Aethlon Medical (NASDAQ:AEMD) Earns Sell Rating from Analysts at StockNews.com - Defense World
AEMD: Aethlon Medical Unveils Study on Innovative Blood Filtrati - GuruFocus
AEMD: Aethlon Medical Unveils Study on Innovative Blood Filtration System | AEMD Stock News - GuruFocus
Aethlon Medical Announces Publication of Preclinical Data Showin - GuruFocus
Revolutionary Blood Filtration Device Shows 98.5% Success Rate in Cancer and Alzheimer's Treatment Study - Stock Titan
Aethlon Medical Approves Key Stockholder Proposals - TipRanks
Comparing Paragon 28 (NYSE:FNA) and Aethlon Medical (NASDAQ:AEMD) - Defense World
Aethlon Medical (NASDAQ:AEMD) Now Covered by Analysts at StockNews.com - Defense World
StockNews.com Begins Coverage on Aethlon Medical (NASDAQ:AEMD) - Defense World
Press Release Distribution & PR Platform - ACCESS Newswire
Aethlon Medical, Inc. (NASDAQ:AEMD) Sees Significant Decline in Short Interest - Defense World
AEMDAethlon Medical Latest Stock News & Market Updates - Stock Titan
Aethlon Medical (NASDAQ:AEMD) Coverage Initiated at StockNews.com - Defense World
Aethlon Medical (NASDAQ:AEMD) Coverage Initiated by Analysts at StockNews.com - Defense World
12 Health Care Stocks Moving In Tuesday's After-Market Session - Benzinga
StockNews.com Initiates Coverage on Aethlon Medical (NASDAQ:AEMD) - Defense World
Exosomes Market Size, Top Share, and Industry Analysis Report by 2033 - Straits Research
Virtu Financial LLC Buys Shares of 94,173 Aethlon Medical, Inc. (NASDAQ:AEMD) - Defense World
Aethlon Medical, Inc. (NASDAQ:AEMD) Short Interest Down 46.7% in March - Defense World
Aethlon Medical at Emerging Growth Virtual Conference: Oncology Focus and Financial Strategy - Investing.com
Aethlon Medical (NASDAQ:AEMD) & Nephros (NASDAQ:NEPH) Head to Head Comparison - Defense World
Aethlon Medical (NASDAQ:AEMD) Now Covered by StockNews.com - Defense World
Aethlon Medical issues new warrants, modifies rights By Investing.com - Investing.com Australia
Aethlon Medical issues new warrants, modifies rights - Investing.com
Short Interest in Aethlon Medical, Inc. (NASDAQ:AEMD) Drops By 52.0% - Defense World
HC Wainwright Reiterates Buy Rating for Aethlon Medical (NASDAQ:AEMD) - The AM Reporter
Aethlon Medical Inc Azioni (AEMD) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
0.01%
0.24%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):